Stargardt Disease: all 66 studies
Page 1 of 1. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 ParticipantsRecruitingNCT07836452Phase 1
- A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye ConditionsRecruitingNCT07734064Phase 1
- Phase 1 Study of C.001 in Retinal DegenerationRecruitingNCT07594236Phase 1
- Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)RecruitingNCT07502664
- Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt DiseaseRecruitingNCT07439887Phase 1/2
- A Study to Learn How Stargardt-type Eye Conditions Progress in Children and AdultsRecruitingNCT07425574
- Study of ALK-001 on the Progression of Stargardt DiseaseRecruitingNCT07419334Phase 3
- A Study of DC6001 Tablet in Healthy Chinese Adult SubjectsRecruitingNCT07417566Phase 1
- Wide Field OCTA in Ocular DiseasesNot yet recruitingNCT07298174
- Restoration of Central Vision With PRIMA in Patients With Photoreceptor DegenerationRecruitingNCT07266584Not applicable
- Inherited Retinal Diseases: Natural History and Genotype-Phenotype CorrelationsNot yet recruitingNCT07265895
- A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)RecruitingNCT07161544Phase 1/2
- An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT DiseaseRecruitingNCT07063251Early Phase 1
- Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease)RecruitingNCT07002398Phase 1/2
- Feasibility and Tolerability Study of Smart Contact Lens With Healthy Subjects and Patients With Stargardt's DiseaseNot yet recruitingNCT06989658Not applicable
- A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)RecruitingNCT06942572Phase 1/2
- A Prospective Observational Study to Assess the Reliability and Validity of the MLSDTRecruitingNCT06805474
- Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)RecruitingNCT06445322
- An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 GeneRecruitingNCT06435000
- Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal DegenerationRecruitingNCT06375239
- The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal DegenerationRecruitingNCT06319872Phase 1
- Structural and Functional Characterization of Rare Ocular DiseasesRecruitingNCT05258032
- Stem Cell Ophthalmology Treatment Study IIRecruitingNCT03011541Not applicable
- Rod and Cone Mediated Function in Retinal DiseaseRecruitingNCT02617966
- Inherited Retinal Degenerative Disease RegistryRecruitingNCT02435940
- Safety and Efficacy of Emixustat in Stargardt DiseaseCompletedNCT03772665Phase 3Results posted
- Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)CompletedNCT03364153Phase 2Results posted
- Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt DiseaseCompletedNCT03033108Phase 2Results posted
- Efficacy of Acupuncture in Macular DiseasesCompletedNCT02255981Not applicableResults posted
- A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective StudiesCompletedNCT01977846Results posted
- Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular DegenerationTerminatedNCT01367444Phase 1/2Results posted
- An Observational Study in Children and Adults With Stargardt DiseaseActive, not recruitingNCT06591806
- Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)Active, not recruitingNCT06467344Phase 1/2
- A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt DiseaseActive, not recruitingNCT06388083Phase 2/3
- ABCA4-associated Disease in Childhood and Adolescence - a Phenotype StudyCompletedNCT06377150
- Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)Active, not recruitingNCT06300476Phase 1/2
- Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT StudyActive, not recruitingNCT06048185
- A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt DiseaseActive, not recruitingNCT05956626Phase 2/3
- The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With MaculopathiesCompletedNCT05904444Not applicable
- Function and Imaging Assessments for G1961E-associated Stargardt DiseaseActive, not recruitingNCT05674058
- Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt DiseaseCompletedNCT05417126Phase 2
- This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt DiseaseCompletedNCT05266014Phase 1/2
- Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt DiseaseCompletedNCT05244304Phase 3
- Pupil Dynamics and Color Vision for the Detection of Eye DiseasesCompletedNCT04909398Not applicable
- Oral Metformin for Treatment of ABCA4 RetinopathyActive, not recruitingNCT04545736Phase 1/2
- Study of STG-001 in Subjects With Stargardt DiseaseCompletedNCT04489511Phase 2
- Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced VisionCompletedNCT04281732
- Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)Active, not recruitingNCT04239625Phase 2
- Stem Cells Therapy in Degenerative Diseases of the RetinaStatus unknownNCT03772938Phase 1
- Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt DiseaseCompletedNCT03297515Not applicable
- A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)CompletedNCT02941991
- Stem Cell Therapy for Outer Retinal DegenerationsCompletedNCT02903576Phase 1/2
- Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic RetinopathyTerminatedNCT02875704
- Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy PatientsCompletedNCT02445612
- The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular DystrophyCompletedNCT02410122
- Phase 2 Tolerability and Effects of ALK-001 on Stargardt DiseaseActive, not recruitingNCT02402660Phase 2
- Phase 1 Safety Study of ALK-001 in Healthy VolunteersCompletedNCT02230228Phase 1
- Stem Cell Ophthalmology Treatment StudyStatus unknownNCT01920867Not applicable
- Microcurrent Stimulation to Treat Macular DegenerationCompletedNCT01790958
- Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular DegenerationActive, not recruitingNCT01736592Phase 2
- Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt DiseaseTerminatedNCT01676766
- Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)CompletedNCT01469832Phase 1/2
- Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular DystrophyCompletedNCT01345006Phase 1/2
- Saffron Supplementation in Stargardt's DiseaseStatus unknownNCT01278277Phase 1/2
- Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular DystrophyCompletedNCT00346853Phase 1
- Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular DystrophyCompletedNCT00060749Phase 1